VA Jagannath, G Filippini… - Cochrane database …, 2018 - cochranelibrary.com
Background This review is an update of a previously published review," Vitamin D for the management of multiple sclerosis"(published in the Cochrane Library; 2010, Issue 12) …
Tumor microenvironment-targeted therapies are emerging as promising treatment options for different cancer types. Tumor-associated macrophages and microglia (TAMs) represent …
R Bagheri, M Ghaedi, A Asfaram, EA Dil, H Javadian - Polyhedron, 2019 - Elsevier
In the present work, the activated carbon (AC) adsorbent with multimodal pore size distribution prepared from Amygdalus scoparia as low-cost and locally available source was …
ED Miller, A Dziedzic, J Saluk-Bijak, M Bijak - Nutrients, 2019 - mdpi.com
Multiple sclerosis (MS) is a complex disease of the central nervous system (CNS). The etiology of this multifactorial disease has not been clearly defined. Conventional medical …
MW Psenicka, BC Smith, RA Tinkey… - Frontiers in cellular …, 2021 - frontiersin.org
The pathology in neurodegenerative diseases is often accompanied by inflammation. It is well-known that many cells within the central nervous system (CNS) also contribute to …
Multiple sclerosis (MS) is a chronic autoimmune inflammatory disease of the central nervous system (CNS), characterized by demyelination, neuronal injury, and breaching of the blood …
Tumor cells overcome anti‐tumor responses in part through immunosuppressive mechanisms. There are several immune modulatory mechanisms. Among them, adenosine …
A Jafarzadeh, M Nemati - Journal of neuroimmunology, 2018 - Elsevier
Multiple sclerosis (MS) is characterized by chronic inflammatory response-induced demyelination of the neurons and degeneration of the axons within the central nervous …
Leakage of the blood–brain barrier (BBB) is a common pathological feature in multiple sclerosis (MS). Following a breach of the BBB, albumin, the most abundant protein in …